OrthoPediatrics Announces Full Commercial Launch of VerteGlide® Spinal Growth Guidance System
Successful Limited Launch Highlights Strong Demand and Adoption of the Company’s Innovative Early Onset Scoliosis Solution Successful Limited Launch Highlights Strong Demand and Adoption of the Company’s Innovative Early Onset Scoliosis Solution
Covered in this story
Analyst targets on Orthopediatrics Corp
- Needham: $30.8 → $35 by Oct 2027 · Buy via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $KIDS yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Orthopediatrics Corp →Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.